Analysis (Figure 7) did show that there was a significant (log rank=4.001, P=0.045) survival trend, patients who presented p53+/hnRNP K+ colorectal tumours (n=119) had a poorer survival outcome compared to patients with tumours of varied p53/hnRNP K expression, n=85 (p53+/hnRNP K-, p53−/hnRNP K+ and p53−/hnRNP K−). This evidence concerns the gene TP53 and neoplasm.